NUTRIEN LTD (NTR) Stock Analyst Ratings
USA - NYSE:NTR - CA67077M1086 - Common Stock
53.32 USD
-1.21 (-2.22%)
ChartMill assigns a Buy % Consensus number of 74% to NTR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 48.48. This target is -9.07% below the current price.
NTR was analyzed by 27 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about NTR.
In the previous month the buy percentage consensus was at a similar level.
NTR was analyzed by 27 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-16 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-14 | B of A Securities | Downgrade | Buy -> Neutral |
| 2025-08-11 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2025-08-11 | TD Securities | Maintains | Buy -> Buy |
| 2025-08-07 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-23 | UBS | Maintains | Neutral -> Neutral |
| 2025-07-17 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-15 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-07-11 | Jefferies | Downgrade | Buy -> Hold |
| 2025-07-07 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-06-26 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-06-17 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2025-05-14 | ScotiaBank | Downgrade | Sector Outperform -> Sector Perform |
| 2025-05-14 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-14 | B of A Securities | Maintains | Buy -> Buy |
| 2025-05-13 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-05-12 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-05-12 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-09 | Goldman Sachs | Maintains | Sell -> Sell |
| 2025-05-08 | UBS | Maintains | Neutral -> Neutral |
| 2025-04-22 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-04-16 | UBS | Maintains | Neutral -> Neutral |
| 2025-03-13 | Goldman Sachs | Initiate | Sell |
| 2025-03-05 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-25 | CIBC | Maintains | Outperformer -> Outperformer |
| 2025-02-24 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-02-24 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-02-21 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-20 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-02-20 | UBS | Maintains | Neutral -> Neutral |
NUTRIEN LTD / NTR FAQ
What is the average price target for NUTRIEN LTD (NTR) stock?
27 analysts have analysed NTR and the average price target is 48.48 USD. This implies a price decrease of -9.07% is expected in the next year compared to the current price of 53.32.
What is the consensus rating for NUTRIEN LTD (NTR) stock?
The consensus rating for NUTRIEN LTD (NTR) is 74.0741 / 100 . This indicates that analysts generally have a positive outlook on the stock.